Amplification and overexpression of the KIT gene is associated with progression in the seminoma subtype of testicular germ cell tumors of adolescents and adults

Cancer Research

Volumn 65, Issue 18, 2005, Pages 8085-8089

  McIntyre, Alan ^a   Summersgill, Brenda ^a   Grygalewicz, Beata ^a   Gillis, Ad J M ^c   Stoop, J ^c   Van Gurp, Ruud J H L M ^a   Dennis, Nening ^a   Fisher, Cyril ^a,b   Huddart, Robert ^b   Cooper, Colin ^a   Clark, Jeremy ^a   Oosterhuis, J Wolter ^c   Looijenga, Leendert H J ^c   Shipley, Janet ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c JOSEPHINE NEFKENS INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; TYROSINE KINASE RECEPTOR;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; CANCER GROWTH; CARCINOMA IN SITU; CHROMOSOME 4Q; DNA FLANKING REGION; EXON; GENE; GENE AMPLIFICATION; GENE MUTATION; GENE OVEREXPRESSION; GERM CELL TUMOR; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KDR GENE; KIT GENE; MAJOR CLINICAL STUDY; MALE; PDGFRA GENE; PRIORITY JOURNAL; SEMINOMA;

ADOLESCENT; ADULT; DISEASE PROGRESSION; GENE AMPLIFICATION; GENE EXPRESSION; HUMANS; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS C-KIT; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR ALPHA; SEMINOMA; TESTICULAR NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 24944431729     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-05-0471     Document Type: Article

References (19)

1. Bosl GJ, Motzer RJ. Testicular germ-cell cancer. N Engl J Med 1997;337:242-53.
2. McIntyre A, Summersgill B, Jafer O, et al. Defining minimum genomic regions of imbalance involved in testicular germ cell tumors of adolescents and adults through genome wide microarray analysis of cDNA clones. Oncogene. Epub 2004 Oct 18.
3. Kemmer K, Corless CL, Fletcher JA, et al. KIT mutations are common in testicular seminomas. Am J Pathol 2004;164:305-13.
4. Looijenga LHJ, de Leeuw H, van Oorschot M, et al. Stem cell factor receptor (c-KIT) codon 816 mutations predict development of bilateral testicular germ-cell tumors. Cancer Res 2003;63:7674-8.
5. Sakuma Y, Sakurai S, Oguni S, Hironaka M, Saito K. Alterations of the c-kit gene in testicular germ cell tumors. Cancer Sci 2003;94:486-91.
6. De Miguel MP, Cheng L, Holland EC, Federspiel MJ, Donovan PJ. Dissection of the c-Kit signaling pathway in mouse primordial germ cells by retroviral-mediated gene transfer. Proc Natl Acad Sci U S A 2002;99:10458-63.
7. Fukuda S, Shirahama T, Imazono Y, et al. Expression of vascular endothelial growth factor in patients with testicular germ cell tumors as an indicator of metastatic disease. Cancer 1999;85:1323-30.
8. Downward J. Targeting RAS signalling pathways in cancer therapy. Nat Rev Cancer 2003;3:11-22.
9. Sawaki A, Yamao K. Imatinib mesylate acts in metastatic or unresectable gastrointestinal stromal tumor by targeting KIT receptors-a review. Cancer Chemother Pharmacol 2004;54 Suppl 1:S44-9.
10. Summersgill BM, Jafer O, Wang R, et al. Definition of chromosome aberrations in testicular germ cell tumor cell lines by 24-color karyotyping and complementary molecular cytogenetic analyses. Cancer Genet Cytogenet 2001;128:120-9.
11. Summersgill B, Osin P, Lu YJ, Huddart R, Shipley J. Chromosomal imbalances associated with carcinoma in situ and associated testicular germ cell tumours of adolescents and adults. Br J Cancer 2001;85:213-20.
12. Honecker F, Stoop H, de Krijger RR, Chris Lau YF, Bokemeyer C, Looijenga LHJ. Pathobiological implications of the expression of markers of testicular carcinoma in situ by fetal germ cells. J Pathol 2004;203:849-57.
13. Palumbo C, van Roozendaal K, Gillis AJ, et al. Expression of the PDGF α-receptor 1.5 kb transcript, OCT-4, and c-KIT in human normal and malignant tissues. Implications for the early diagnosis of testicular germ cell tumours and for our understanding of regulatory mechanisms. J Pathol 2002;196:467-77.
14. Bokemeyer C, Kuczyk MA, Dunn T, et al. Expression of stem-cell factor and its receptor c-kit protein in normal testicular tissue and malignant germ-cell tumours. J Cancer Res Clin Oncol 1996;122:301-6.
15. Izquierdo MA, Van der Valk P, Van Ark-Otte J, et al. Differential expression of the c-kit proto-oncogene in germ cell tumours. J Pathol 1995;177:253-8.
16. Rajpert-De Meyts E, Kvist M, Skakkebaek NE. Heterogeneity of expression of immunohistochemical tumour markers in testicular carcinoma in situ: pathogenetic relevance. Virchows Arch 1996;428:133-9.
17. Caruana G, Cambareri AC, Gonda TJ, Ashman LK. Transformation of NIH3T3 fibroblasts by the c-Kit receptor tyrosine kinase: effect of receptor density and ligand-requirement. Oncogene 1998;16:179-90.
18. Rapley EA, Hockley S, Warren W, et al. Somatic mutations of KIT in familial testicular germ cell tumours. Br J Cancer 2004;90:2397-401.
19. Sommerer F, Hengge UR, Markwarth A, et al. Mutations of BRAF and RAS are rare events in germ cell tumours. Int J Cancer 2005;113:329-35.